GLPG0187 inhibited the progression of bone metastasis. Maximum efficacy of inhibition of bone metastasis was achieved when GLPG0187 was combined with the standard-of-care metastatic breast cancer treatments.
Molecular Weight:
595.71
Purity:
>98.5%
CAS Number:
[1320346-97-1]
Formula:
C29H37N7O5S
Target:
Integrin
* VAT and and shipping costs not included. Errors and price changes excepted